Skip to content

Pathological and clinical characteristics of prostate biopsy cases with PSA level between 0-4.0ng/mL: a multicenter retrospective real-world study

Pathological and clinical characteristics of prostate biopsy cases with PSA level between 0-4.0ng/mL: a multicenter retrospective real-world study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102978
Enrollment
Unknown
Registered
2025-05-22
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate tumor

Interventions

Non-malignant tumor group (Negative prostate biopsy result):None
Malignant tumor group (Positive prostate biopsy result):None

Sponsors

Ningbo First Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.The patient underwent prostate biopsy and obtained pathological diagnosis results; 2.The patient's PSA level before biopsy is below 4ng/mL;

Exclusion criteria

Exclusion criteria: 1.Patient pathological result data is missing; 2.The patient has undergone radical prostatectomy or electroresection surgery in the past; 3.The patient has been taking finasteride drugs for a long time (>6 months) before biopsy or has received endocrine therapy, which affects the PSA value;

Design outcomes

Primary

MeasureTime frame
Gleason Score;Prostate tumor detection rate;

Countries

China

Contacts

Public ContactQi Ma

Ningbo First Hospital

45112409@qq.com+86 574 8708 9078

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026